US 9737623
Antibodies that bind activatable antibodies and methods of use thereof
granted A61KA61K2039/505A61K51/1078
Quick answer
US patent 9737623 (Antibodies that bind activatable antibodies and methods of use thereof) held by CytomX Therapeutics, Inc. expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61K51/1078